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Keratinocytes Synthesize Enteropeptidase and
Multiple Forms of Trypsinogen during Terminal
Differentiation
Jotaro Nakanishi1, Mami Yamamoto1,2, Junichi Koyama1, Junko Sato1 and Toshihiko Hibino1
Members of the trypsin-like and chymotrypsin-like kallikrein family are important in the desquamation process.
In this study, we isolated cDNA clones encoding trypsinogen 4 (brain trypsinogen) and a previously unreported
isoform of trypsinogen from a human keratinocyte cDNA library. The nucleotide sequence of the new isoform
only differs from those of trypsinogen 3 (mesotrypsinogen) and trypsinogen 4 in an exon encoding the
N-terminal region, indicating that this isoform is an alternative splicing variant of the mesotrypsinogen gene
PRSS3. Both isoforms contained the sequence DDDDK-I, a putative cleavage site for activation by
enteropeptidase. Thus, after activation, mesotrypsin would be produced. Immunohistochemical and in situ
hybridization studies revealed that trypsinogens were expressed and localized in the upper epidermis,
especially in the granular layer. In cultured keratinocytes, enteropeptidase mRNA was expressed at
the confluent stage, and its expression was strongly upregulated after air exposure. Interestingly, it was
synthesized and localized only at the granular layer, suggesting that the generation of active mesotrypsin is
restricted to this layer. The enteropeptidase-cleavage product was also found at the same layer. When a skin
equivalent model was cultured in the medium without air exposure, the cornified layer was not formed, and
many cells expressed trypsinogens and enteropeptidase. Those cells were found to be TUNEL positive. Because
mesotrypsin is resistant to naturally occurring trypsin inhibitors, confined expression of the isoforms of
mesotrypsinogens and enteropeptidase may indicate that mesotrypsin is involved in keratinocyte terminal
differentiation.
Journal of Investigative Dermatology (2010) 130, 944–952; doi:10.1038/jid.2009.364; published online 19 November 2009
INTRODUCTION
Stratum corneum (SC), the outermost layer of epidermis,
consists of cornified cells (corneocytes) and continuous
extracellular lipid layers, forming a physicochemical barrier
that efficiently protects the body from environmental hazards.
The SC is continuously produced through the terminal
differentiation of keratinocytes. At the same time, cell
shedding (desquamation) also occurs to maintain a constant
thickness of the SC. In normal desquamation, individual
corneocytes or small aggregates become detached from the
skin surface. The process is imperceptible to healthy
individuals, but in some pathological conditions there
is an imbalance between SC production and desquamation,
which results in excessive visible scales. This is seen in
inflammatory skin diseases such as psoriasis (Fartasch, 1997;
Langley et al., 2005).
Lundstrom and Egelrud reported that a chymotrypsin-like
serine protease is present in the SC and that it is involved in
desquamation (Lundstrom and Egelrud, 1990; Egelrud and
Lundstrom, 1991). This enzyme was purified as stratum
corneum chymotryptic enzyme from human plantar SC, and
cDNA encoding stratum corneum chymotryptic enzyme was
isolated from a human keratinocyte cDNA library (Egelrud,
1993; Hansson et al., 1994). We have shown that not only a
chymotryptic enzyme, but also trypsin-like serine protease(s)
is involved in the desquamation process of nonplantar SC
(Suzuki et al., 1993, 1994, 1996). Recent studies have
revealed that a human tissue kallikrein gene family encoding
15 serine proteases, designated kallikrein 1-15 (KLK1-15), is
located as a cluster on chromosome 19q13.4 (Harvey et al.,
2000; Clements et al., 2001). Many of these serine proteases
are widely expressed in human tissues (Harvey et al., 2000),
including skin (Komatsu et al., 2005). The proteases
previously identified as being involved in desquamation
were then renamed as kallikrein family members: stratum
corneum chymotryptic enzyme was renamed kallikrein 7
(KLK7, hK7) (Yousef et al., 2000) and trypsin-like enzyme
(Brattsand and Egelrud, 1999; Ekholm et al., 2000; Caubet
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et al., 2004) was renamed KLK5 (hK5). There is much
evidence that KLK5 and KLK7 have critical functions in
desquamation. Furthermore, Komatsu et al. (2005) showed
that KLK6, KLK8, KLK10, KLK11, KLK13 and KLK14 are also
present in the SC, and suggested that these enzymes might
also be involved in desquamation, acting as a proteolytic
cascade. This would be consistent with the finding that KLK5
activates KLK7 and KLK14 at weakly acidic pH (Brattsand
et al., 2005).
On the other hand, three different trypsinogens were
present in human pancreatic juice. On the basis of their
isoelectric points, they are called cationic trypsinogen,
anionic trypsinogen and mesotrypsinogen. Recent studies
revealed that these trypsinogens are encoded by distinct
genes, PRSS1, PRSS2 and PRSS3, respectively (Sahin-Toth,
2005). The PRSS1 gene product, trypsinogen 1 and the PRSS2
gene product, trypsinogen 2 are major digestive pancreatic
proteases. The PRSS3 is the mesotrypsinogen gene and at
least two splicing variants would be produced (trypsinogens 3
and 4). All of these trypsinogens possess the putative cleavage
site sequence DDDDK-I for the activation by enteropeptidase
(Light and Janska, 1989). Trypsinogens are expressed not only
in the pancreas, but also in other tissues, including epithelial
cells of various tissues (Koshikawa et al., 1997) and human
brain (Wiegand et al., 1993). Interestingly, mesotrypsin differs
from other two trypsins in its substrate specificity and
inhibitor susceptibility. Mesotrypsin cleaves protein sub-
strates poorly. The most characteristic feature is the resistance
to the naturally occurring trypsin inhibitors, such as
a1-trypsin inhibitor, pancreatic secretory trypsin inhibitor
(Kazal type), soybean trypsin inhibitor (Kunitz type)
(Rinderknecht et al., 1984; Nyaruhucha et al., 1997). These
findings indicate that trypsin could be involved in various
physiological reactions, in addition to intestinal digestion.
Here we report the cDNA cloning of trypsinogen genes
from a human keratinocyte cDNA library. We isolated two
splicing isoforms of mesotrypsinogen gene PRSS3, of which
one is identical with trypsinogen 4 (brain trypsinogen) and
the other is a previously unknown isoform, differing only in
the exon encoding the N-terminal region. Both isoforms
contain the activation sequence DDDDK-I, and we found
that the activating enteropeptidase was localized exclusively
in the granular layer of the epidermis. The characteristic
expression and localization of these trypsinogens and the
activating enzyme are consistent with the idea that meso-
trypsin is involved in keratinocyte terminal differentiation.
RESULTS
Molecular cloning of trypsinogens from a human keratinocyte
cDNA library
Reverse transcriptase (RT)–PCR amplification using a degen-
erate primer pair (see Materials and Methods section) yielded
540-bp PCR products, which were subcloned into the pCRII
vector. The sequences of all clones tested were identical with
that of trypsinogen 3 or 4, and one of the clones (Tryp 1) was
used as a probe for screening of a human keratinocyte cDNA
library in the lgt11 vector. Among 50 positive clones, two
contained an open reading frame of 912 nucleotides, which
encodes 304 amino acids. The encoded product was
identified as trypsinogen 4 (brain trypsinogen) (data not
shown; DDBJ/EMBL/GenBank accession number AB298285).
Of these 50 positive clones, 46 were also categorized as
trypsinogen 4 by sequence analysis, although they did not
contain the full-length open reading frame. The remaining
two clones had an open reading frame of 720 nucleotides,
which encodes a 240-amino-acid isoform of trypsinogen.
To our knowledge, this is previously unreported and
registered at DDBJ/EMBL/GenBank (accession number
AB298286; Figure 1).
Comparison of the deduced amino-acid sequence of the new
isoform with known trypsinogen sequences
The nucleotide sequence and the deduced amino-acid
sequence of the new isoform differ from those of trypsinogens
3 and 4 in the sequence at the N-terminal region (Figure 2).
The deduced amino-acid sequence of the N-terminal region
for this isoform, MGPAGEVAV, is the shortest among the
trypsinogens, and we named this new isoform trypsinogen 5.
This enzyme contains the putative activation cleavage site
(DDDDK-I), and after cleavage, this isoform, as well as
trypsinogen 4, generates an enzyme identical with meso-
trypsin. A major characteristic feature of mesotrypsin is
arginine at position 191 of trypsinogen 5, in proximity to the
active serine at position 193. It has been reported that this
single mutation from glycine of other trypsins (cationic and
anionic trypsins) to arginine in mesotrypsin is responsible for
the lack of susceptibility of mesotrypsin to natural trypsin
inhibitors (Szmola et al., 2003).
Genomic organization of epidermal trypsinogens
The genomic organization of the exons encoding the
N-terminal region of trypsinogens 3, 4 and 5 is shown in
Figure 3. These isoforms use three different exons for the ATG
start codon. The exon encoding the N terminus of the new
isoform (trypsinogen 5) was found just behind the exon
encoding the N terminus of trypsinogen 4 on the reported
human genomic DNA sequence (Wiegand et al., 1993).
These segments are located at 45-kb upstream of the exon
used for trypsinogen 3, indicating that these trypsinogens are
splicing variants of the PRSS3 gene.
Tissue distribution and expression of trypsinogens 4 and 5
The expression of trypsinogens 4 and 5 mRNAs in various
human tissues was examined by RT–PCR. As shown in Figure
4a, trypsinogen 4 mRNA was expressed in all tissues and cells
tested, brain, heart, lung, liver, stomach, small intestine,
pancreas, spleen, kidney, prostate, testis, uterus, placenta,
skin fibroblasts and keratinocytes, except skeletal muscle. In
contrast, expression of trypsinogen 5 was restricted to brain,
stomach, small intestine, uterus, fibroblasts and keratino-
cytes. The expression of pancreatic trypsinogens (trypsino-
gens 1, 2 and 3) was observed only in pancreas and lung
(data not shown). We also performed northern blot analysis
for the identification of trypsinogen mRNAs. In cultured
keratinocytes, only one trypsinogen mRNA (probably trypsi-
nogen 4) was shown (Figure 4b). Because trypsinogen 5 was
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supposed to be a minor species compared with trypsinogen 4
as shown in the cloning process (2 clones vs 48 clones), we
assume that our current method for northern blot would not
have enough sensitivity to detect trypsinogen 5.
Western blot analysis showed the presence of 34 and
26 kDa bands in the extracts from proliferating keratinocytes
(80% confluent) as well as differentiated keratinocytes
(confluent and air exposed; Figure 4c). These bands are
likely to correspond to trypsinogens 4 and 5 from the
deduced molecular weights of 32,498 and 25,807Da,
respectively. In addition, a 24 kDa band was detected only
in the extract from the differentiated keratinocytes, indicating
the presence of active mesotrypsin in this preparation. In
addition, we analyzed the presence of trypsinogens and
trypsins in various tissue extracts by western blot (Figure 4d).
We found that the major form of trypsinogen was detected
near 34 kDa, which was predominant in pancreas, followed
by lung, liver and kidney. Only a weak band with 34 kDa was
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Figure 1. The nucleotide and deduced amino-acid sequences of the new isoform of trypsinogen. The nucleotide sequence data have been submitted to
the DDBJ/EMBL/GenBank databases with the accession number AB298286. The unique sequence encoding the N-terminal region is indicated with an
underline. One-letter codes for amino acids are shown in the lower line. An arrowhead indicates the enteropeptidase activation site. Active site serine (S193) and
a critical amino acid responsible for inhibitor resistance (R191) are boxed.
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Figure 2. Comparison of the deduced amino-acid sequences of human trypsinogens. Trypsinogens 1 (cationic trypsinogen) and 2 (anionic trypsinogen) are
encoded by the PRSS1 and PRSS2 genes, respectively. Trypsinogens 3 (mesotrypsinogen), 4 (brain trypsinogen) and 5 (new isoform) are encoded by the PRSS3
gene. Those amino acids that are different among five trypsinogens are shown with a white background. Arrowheads show the conserved catalytic triad of amino
acids. An arrow indicates a unique amino acid arginine (R) that characterizes inhibitor resistance in mesotrypsin.
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found for brain. In heart, trypsinogen was hardly detectable.
Relatively abundant low molecular weight species with
26 kDa was shown for colon and liver.
Expression and localization of trypsinogens in human skin
We examined the expression and localization of trypsinogen
in human skin. First, we performed in situ hybridization using
a digoxigenin (DIG)-labeled cRNA probe that recognizes all
trypsinogen mRNAs (Figure 5a). In the epidermis, trypsinogen
mRNAs were expressed in suprabasal cells, especially in
granular cells. On the other hand, no expression was
observed in basal cells. An immunohistochemical study
using anti-trypsin antibody showed a rather confined
localization of trypsin(ogen)s in the upper epidermis, mostly
in granular cells (Figure 5b). Nonimmune normal rabbit IgG
was used as a negative control and did not show any positive
staining except a weak staining at the edge of the epidermis,
which indicates nonspecific staining (Figure 5c).
Expression of enteropeptidase in human keratinocytes and
epidermis
Because epidermal trypsinogens contain the enteropeptidase
activation sequence (DDDDK-I), we investigated the expres-
sion of enteropeptidase mRNA in cultured keratinocytes
(Figure 6a). RT–PCR showed that enteropeptidase was
expressed at the confluent stage, and was unaffected by a
high calcium concentration. In contrast, when keratinocytes
were exposed to air and further incubated in the presence of
high calcium concentration, the expression of enteropepti-
dase was strongly upregulated. In situ hybridization study
showed that enteropeptidase mRNA was detected only in
those cells that aggregated and piled up after strong
differentiation stimuli (confluent and air exposed; Figure
6b). In the human skin, the enteropeptidase mRNA was
detected exclusively in the granular layer (Figure 6c).
Interestingly, the staining was confined to a very limited
number of granular cells.
Mesotrypsinogen (Trypsinogen 3)
New isoform (Trypsinogen 5)
Brain trypsinogen (Trypsinogen 4)
Figure 3. Genomic organization of the exons encoding the N-terminal region of three isoforms of PRSS3 gene. The coding sequences including ATG start
codon of three isoforms are given in capital letters. The exon–intron junctions are underlined, although the 50-ends of these exons are undetermined.
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Figure 4. Expression of trypsinogen isoforms in skin and various tissues.
(a) mRNA expression of trypsinogens 4 and 5 in various tissues. Reverse
transcriptase (RT)–PCR products were detected by Southern blotting as
described in the Materials and Methods section. Lane 1, brain; 2, heart; 3,
lung; 4, liver; 5, stomach; 6, small intestine; 7, pancreas; 8, spleen; 9, kidney;
10, prostate; 11, testis; 12, uterus; 13, placenta; 14, skeletal muscle; 15,
keratinocytes; 16, fibroblasts. (b) Northern blot analysis of epidermal
trypsinogen in cultured human keratinocytes. Only a single species
(trypsinogen 4) can be detected probably due to the abundance of this
trypsinogen. (c) Western blot analysis of trypsinogens and trypsins in
keratinocytes. Extracts obtained from proliferating keratinocytes and
prolonged culture after differentiation were examined. (d) Western blot
analysis of trypsinogens and trypsins in various tissue extracts.
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Localization of enteropeptidase and its cleavage product in
human skin
Immunohistochemical study showed that enteropeptidase
was localized also in the very confined area of granular cells
(Figure 7a). This was coincided with the results of in situ
hybridization. Furthermore, staining with an antibody direc-
ted to the enteropeptidase cleavage site (ECS) (DDDDK-I)
revealed that the cleavage product was present similarly at
the granular layer (Figure 7b). These results suggest that the
conversion of trypsinogen to trypsin was occurring at the very
restricted site of the granular layer.
Analyses with skin equivalent models
We performed limited attempts to elucidate physiological
functions of enteropeptidase–trypsin system using skin
equivalent models (Figure 8). For this purpose, we prepared
two kinds of models: one is normally lifted to the air–liquid
interface (air exposed; Figure 8, left panels) and the other was
immersed in the medium throughout the experiments
(dipped; right panels). Immunostaining of trypsin(ogen)s
showed broader localization from basal to granular cells
(Figure 8a, left) compared with the healthy human skin. In
contrast, morphological difference was evident in the dipped
Anti-sense Sense
Anti-trypsin + DAPI Anti-trypsin
Normal IgG + DAPI Normal IgG
Figure 5. Expression and localization of trypsinogen in human skin. (a) In situ
hybridization of trypsinogen in human epidermis. Anti-sense (left) and sense
(right) cRNA probes that recognize all trypsinogens were prepared as
described in the Materials and Methods section. Color was developed with
Vector Red. (b) Immunohistochemical localization of trypsinogen. Rabbit
anti-human trypsin IgG that recognizes all trypsin isoforms was used as a
primary antibody. Fluorescence detection was performed using Alexa Fluor
555 and nuclear staining was carried out with 40,6-diamino-2-phenylindole.
Lower (left) and higher (right) magnifications are shown. Nonimmune normal
rabbit IgG was used as a negative control. Outermost cornified layer is
marked with a dotted white line. Dermo-epidermal junction is delineated
with a broken white line. Bar¼ 50mm.
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Figure 6. Expression of enteropeptidase in human keratinocytes and skin.
(a) mRNA expression of enteropeptidase in human keratinocytes at various
stages of culture condition. Reverse transcriptase (RT)–PCR products were
visualized with ethidium bromide (upper panel) and analyzed with Southern
blotting by means of the enteropeptidase-specific cDNA probe. (b) In situ
hybridization of enteropeptidase in cultured human keratinocytes.
Keratinocytes were cultured until the confluent monolayer. After removing
the medium, keratinocytes were kept for 15minutes in the air with lid and
further incubated for 2 days in the serum-free medium including 2mM
Ca2þ (left). In situ hybridization of enteropeptidase was performed as
described in the Materials and Methods section (right). Bar¼ 20mm. (c)
In situ hybridization of enteropeptidase in human epidermis. Color images are
developed with Vector Red. Lower (left) and higher (right) magnifications are
shown. Bar¼ 100mm.
Enteropeptidase + DAPI Enteropeptidase
ECS + DAPI ECS
Figure 7. Localization of enteropeptidase and its cleavage product in human
epidermis. (a) Enteropeptidase is present in the granular layer (left). An
enlarged figure is also shown (right). Staining of the skin surface was
nonspecific. (b) The enteropeptidase-cleavage product is present similarly in
the restricted area of granular cells (left). An enlarged figure is also shown
(right). Outermost cornified layer is marked with a dotted white line. Dermo-
epidermal junction is delineated with a broken white line. Bar¼100 mm.
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culture model (Figure 8a, right). The cornified layer was not
formed and stratified structure was no more observed.
Trypsin(ogen)s were expressed strongly in some particular
cells and many of these cells were TUNEL positive. In the
air-exposed culture, TUNEL-positive cells could not be
found (Figure 8b, left). In the dipped culture, continuous
staining was not observed and enteropeptidase-positive
cells showed scattered distribution (Figure 8b, right). TUNEL
staining showed that most of these cells were dying
by apoptosis. ECS was detected similarly and these cells
were also TUNEL-positive.
DISCUSSION
Previous studies have shown that trypsin-like and chymo-
trypsin-like serine proteases are present in human SC and are
involved in the process of desquamation (Lundstrom and
Egelrud, 1990; Egelrud and Lundstrom, 1991; Suzuki et al.,
1993, 1994, 1996). These enzymes are currently classified as
members of the kallikrein family. The activities of the
epidermal kallikreins toward corneodesmosome proteins
have been well characterized (Caubet et al., 2004), and the
existence of a proteolytic cascade of kallikreins in the SC has
been reported (Brattsand et al., 2005). On the other hand, it
has not been clear whether trypsin(ogen) itself is expressed in
the skin.
In this study, we have cloned two kinds of trypsinogen
cDNAs, which encode trypsinogen 4 (brain trypsinogen) and
its new alternative splicing variant, from a human keratino-
cyte cDNA library. We named the new isoform trypsinogen
5. The trypsinogen 4 gene has already been cloned from
human brain by means of the RACE (rapid amplification of
cDNA ends) technique, but it did not contain an ATG-start
codon (Wiegand et al, 1993), probably because the GC-rich
sequence in the 50-region caused incomplete reverse
transcription or PCR amplification. Here, we succeeded in
obtaining the complete sequence including the ATG-start
codon. As shown in Figure 3, it appears that trypsinogens 3
(mesotrypsinogen), 4 (brain trypsinogen) and 5 (new isoform)
are derived from the same gene, PRSS3. Interestingly, the
active forms of these isoforms are identical with mesotrypsin,
indicating that the differences in the N-terminal regions are
associated with the tissue-specific expression of these
trypsinogens. Indeed, mRNA expression of trypsinogen 5
was quite restricted and only found in brain, stomach, small
intestine, uterus, fibroblasts and keratinocytes. In contrast,
trypsinogen 4 was detected in all the tissues except skeletal
muscle tested in this study (Figure 4a). Western blot analysis
showed that trypsinogens were expressed in many tissues
except heart, although their expression levels varied from
tissue to tissue (Figure 4d). Thus, it is quite likely that trypsins
are necessary not only for digestive processes but also for
comprehensive physiological reactions in many tissues.
According to the deduced amino-acid sequence (Figure 2),
trypsinogens 4 and 5 lack a signal peptide sequence,
unlike trypsinogens 1, 2 and 3, suggesting an intracellular
function. However, it remains possible that epidermal
trypsin(ogen)s may be secreted into the extracellular space
by lamellar bodies. In the transition between the stratum
granulosum and the SC, the lamellar bodies fuse with the
plasma membrane and secrete their contents to the SC
extracellular space. Kallikreins are transported to the extra-
cellular space by lamellar bodies (Menon et al., 1992;
Sondell et al., 1995). The same system may be used for
trypsin(ogen)s.
Trypsinogens 4 and 5 both contain the activation cleavage
site (DDDDK-I), which is a highly conserved sequence found
in pancreatic trypsinogens from various species (Bricteux-
Gregoire et al., 1971). The sequence DDDDK-I is poorly
cleaved by trypsin itself, because of the predominance of
negatively charged residues at the cleavage site (Abita et al.,
Air-exposed
Air-exposed Dipped
Dipped
Trypsin (ogen) + DAPI
Trypsin (ogen) + TUNEL
Trypsin (ogen) + DAPI
Trypsin (ogen) + TUNEL
Enteropeptidase Enteropeptidase + DAPI
ECS Enteropeptidase + TUNEL
Merge ECS + TUNEL
Figure 8. Analyses with skin equivalent models. Two different skin
equivalent models were prepared. One is normally developed by lifting the
model to an air–liquid interface (left panels). The other is kept in the medium
throughout the experiment (right panels). (a) Immunostaining for
trypsin(ogen)s with nuclei staining is shown in the upper panel. Lower panel
shows double staining for trypsin(ogen)s and TdT-mediated dUTP-biotin nick
end labeling (TUNEL). Many TUNEL-positive cells are observed only in the
dipped model (lower right). (b) Immunostaining of enteropeptidase and
enteropeptidase cleavage site (ECS) with a merged figure is shown for the air-
exposed culture (left panels). Enteropeptidase with nuclear staining and
double stainings for enteropeptidase þ TUNEL and ECS þ TUNEL are shown
in the dipped culture model (right panels). Outermost cornified layer is
marked with a dotted white line. Dermo-epidermal junction is delineated
with a broken white line. Bar¼ 100mm.
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1969). In contrast, enteropeptidase has high specificity for
the DDDDK-I sequence (Light and Janska, 1989). For
example, the catalytic efficiency of bovine enteropeptidase
is 34,000-fold greater than that of bovine trypsin toward
bovine trypsinogen (Anderson et al., 1977). Therefore,
enteropeptidase is the only enzyme capable of physiologically
converting trypsinogen to trypsin. The expression of enter-
opeptidase has been reported to be abundant in small
intestine and duodenal mucosa of various species, but there
is no information about the expression in other tissues, except
for one report of weak mRNA expression in stomach, colon
and brain of rat (Yahagi et al., 1996).
In this study, we have detected strong expression of
enteropeptidase mRNA and the protein exclusively in the
granular layer of human epidermis (Figures 6c and 7a). The
expression of this enzyme may be associated with the final
stage of the terminal differentiation; indeed significant
upregulation was observed only when the monolayer culture
was exposed to air after confluency (Figure 6a). On the other
hand, trypsinogen was expressed from the suprabasal layer to
the granular layer, and heavy immunostaining for the protein
was observed at the granular layer (Figure 5), indicating that
the activation of epidermal trypsinogens is tightly regulated
spatiotemporally and is dependent on enteropeptidase.
Indeed by use of an antibody directed to the ECS (DDDDK-
I), we confirmed that its cleavage product was present
similarly at the granular layer of the human epidermis.
Because of its unique sequence, it is highly likely that
mesotypsin is generated at the same site.
During terminal differentiation, many events are asso-
ciated with proteolytic action. In the uppermost granular
cells, the nuclei and all organelles disappear, the molecular
weights of keratins decrease (Fuchs and Green, 1980;
Bowden et al., 1984) and profilaggrin is processed to filaggrin
(Fleckman et al., 1985). Recent investigations have shown the
importance of the serine protease inhibitor, lympho-epithe-
lial-Kazal-type-5 inhibitor (LEKTI) in desquamation. Mutation
of LEKTI gene, SPINK5, was identified as a defective gene in
patients with a severe autosomal recessive ichthyosiform skin
condition known as Netherton syndrome (Chavanas et al.,
2000). The major desquamation proteases KLK5 and KLK7
are strongly inhibited by LEKTI (Schechter et al., 2005).
SPINK5-deficient mice show hyperactivity of epidermal
proteases and mimic Netherton syndrome through excessive
degradation of desmoglein 1 (Descargues et al., 2005).
Multiple epidermal kallikreins may also participate in
desquamation through cleavage of desmoglein 1, and they
are regulated by LEKTI (Borgono et al., 2007).
Apparently, these events are regulated by the balance
between proteases and protease inhibitors. Because epider-
mal trypsins are identical with mesotrypsin, the active
enzymes are inhibitor resistant (Nyaruhucha et al., 1997).
Furthermore, mesotrypsin is a unique digestive protease for
naturally occurring trypsin inhibitors (Szmola et al., 2003;
Sahin-Toth, 2005). Thus, once mesotrypsin is generated, it
will change the balance between kallikreins and LEKTI. It is
tempting to speculate that overactivation of mesotrypsin has
similar effect with loss of LEKTI, causing proteolysis of the
cornified layer (Hachem et al., 2006). Using skin equivalent
models, we made a limited attempt to find a clue to
physiological functions of mesotrypsin in the epidermis. In
the dipped culture model, we showed that cornified layer
could not be formed because of the apoptosis of keratinocyte.
Interestingly, those keratinocytes showed colocalization of
trypsin(ogens), enteropeptidase and its cleavage product with
TUNEL positivity (Figure 8). Our findings suggest that
epidermal mesotrypsin may have a critical function in
terminal differentiation and desquamation. Deregulation of
this enzyme could be a critical event that would cause
abnormal differentiation and disorders of the skin.
MATERIALS AND METHODS
Cell culture
Human keratinocytes derived from normal foreskin (Cascade Biologics,
Portland, ME) were cultured in keratinocyte growth medium composed
of MCDB 153 medium supplemented with epidermal growth factor
(0.1ngml1), insulin (10mgml1), hydrocortisone (0.5mgml1), bovine
pituitary extract (0.4%), gentamicin (50mgml1) and amphotericin B
(50ngml1). Human dermal fibroblasts derived from normal foreskin
(Cascade Biologics) were cultured in Dulbecco’s modified Eagle’s
medium supplemented with 5% fetal bovine serum, gentamicin
(50mgml1) and amphotericin B (50ngml1). All experiments were
carried out on cells at the third passage. In some experiments,
keratinocytes were cultured until the fully confluent condition. After
the removal of the medium, keratinocytes were exposed to air for
15minutes with a lid (culture dish) or 30minutes in the capped flask and
incubated further 2 days with the medium containing 2mM CaCl2.
Skin samples
Biopsy samples were obtained at the Tokyo Medical University Hospital
under informed consent and were used for immunohistochemical and in
situ hybridization analyses. The study was approved by the Committee
of Ethical Matters at the Tokyo Medical University School of Medicine
and by the Shiseido Committee on Human Ethics. The study was
conducted according to the Declaration of Helsinki Principles.
RT–PCR amplification and cDNA library screening
The following degenerate oligonucleotide primer pair, which
corresponds to consensus sequences of human trypsinogens, was
designed: sense primer 50-TTCTGIGGIGGCTCCCTCAT-30, antisense
primer 50-AGGCITGTTCITCTGGGCAC-30. Total RNA (500ng) isolated
from cultured human keratinocytes was reverse transcribed using
random hexamer and Superscript II RNase H-reverse transcriptase
(Gibco-BRL, Gaithersburg, MD) and then subjected to PCR amplifica-
tion using Taq DNA polymerase (Takara, Kyoto, Japan) and the above
primers. Forty cycles of amplification were performed at 94 1C for
30 seconds, 60 1C for 1minute and 72 1C for 1minute. The PCR
products of the expected size (540bp) were gel-purified and subcloned
into the pCR II vector (Invitrogen, San Diego, CA). The inserted PCR
products were confirmed by a combination of restriction enzyme
mapping and DNA sequencing. The sequences of all clones tested
were identical with the sequences of PRSS3, and one of the clones
(Tryp 1) was used as a probe for screening of a human keratinocyte
cDNA library in the bacteriopharge lgt11 vector (Clontech, Mountain
View, CA). DIG-labeled cDNA probes were prepared by PCR
amplification of the insert using the primers and DIG-dUTP. Screening
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was performed under high-stringency conditions and the obtained
cDNA inserts of plaque-purified isolates were subcloned into
pBluescript II KSþ (Stratagene, La Jolla, CA) for DNA sequencing.
mRNA detection by RT–PCR
Total RNA from various tissues and cells (500 ng in each case) was
reverse transcribed and then subjected to PCR amplification using
specific forward primers for each type of trypsinogen; for detection
of trypsinogens 1–3, degenerate forward primer 50-ATCCA(C/
T)TCCTGATCCTT(A/G)CC-30, for trypsinogen 4 specific forward
primer 50-TTCTGGGTGGACGCACTTGG-30, for trypsinogen 5
specific forward primer 50-GTTCCGACTCGCATGGGACC-30 and
the common reverse primer for the trypsinogen family
50-GGTAATCTTTCCAGGGTAGG-30 were used. For enteropeptidase
detection, the forward primer 50-agctcaagacatcaccccaa-30 and the
reverse primer 50-aaaccttgagaccctggcat-30 were used. The glycer-
aldehyde-3-phosphate dehydrogenase gene was also amplified using
the forward primer 50-CCTGCTTCACCACCTTCT-30 and the reverse
primer 50-CCCATCACCATCTTCCAG-30, as a control for the amount
of RNA loaded. Thirty cycles of amplification for trypsinogens and
enteropeptidase, and 20 cycles for glyceraldehyde-3-phosphate
dehydrogenase were performed at 94 1C for 30 seconds, 60 1C for
1minute and 72 1C for 1minute. The PCR products were electro-
phoresed through 2% agarose gel and visualized by ethidium bromide
staining and southern hybridization. PCR amplification of each RNA
sample without reverse transcription was performed to verify the
absence of genomic DNA contamination in each sample. Each
product was digested with restriction enzyme to confirm its identity.
Southern hybridization
For Southern blot analysis of trypsinogens and enteropeptidase RT–PCR
products, DIG-labeled cDNA probes were prepared using each PCR
product as a template. After PCR and agarose gel electrophoresis, gel
was stained with ethidium bromide, denatured in 0.5N NaOH
containing 1.5M NaCl and transferred onto a nylon membrane.
After fixation of DNA by UV cross-linking, hybridization was carried
out at 65 1C overnight. The membrane was incubated with anti-DIG
alkaline phosphatase conjugate and visualized with nitro-blue
tetrazolium chloride/5-bromo-4-chloro-30-indolylphosphate-p-tolui-
dine salt (Roche Diagnostics, Indianapolis, IN).
Northern hybridization
Total RNA samples (1mg) from cultured keratinocytes were subjected
to electrophoresis in formaldehyde buffer and transferred onto a nylon
membrane. After fixation of RNA by UV cross-linking, hybridization
was carried out at 50 1C overnight with DIG-labeled cDNA probe
synthesized from Tryp 1 plasmid by PCR. The membrane was
incubated with anti-DIG horseradish peroxidase conjugate (Roche
Diagnostics) and visualized with enhanced chemiluminescence plus
reagents (GE Healthcare, Little Chalfont, UK).
In situ hybridization
In situ hybridization was performed on paraffin-embedded human
skin sections. Human scalp skin sections were obtained with
informed consent from patients who have undergone plastic surgery.
DIG-labeled antisense and sense cRNA probes were synthesized
from linearized Tryp 1 plasmid by in vitro transcription using a DIG
RNA Labeling Kit (SP6/T7) (Boehringer Mannheim, Indianapolis, IN)
according to the manufacturer’s manual. Similarly, a cRNA probe
for enteropeptidase was prepared from the PCR product as des-
cribed above. The hybridization buffer consisted of 50% formamide,
5 SSC, 5 Denhardt’s solution and the DIG-labeled probe
(100 ngml1), and hybridization was allowed to proceed at 55 1C for
16 hours. After posthybridization washing, the tissue sections were
incubated with anti-DIG alkaline phosphatase conjugate (Boehringer
Mannheim) and visualized with Vector Red (Vector Laboratories,
Burlingame, CA) according to the manufacturer’s manual.
Immunohistochemistry and TUNEL
Biopsy specimens (abdominal skins) were fixed with 4% parafor-
maldehyde. Anti-human cationic trypsin (rabbit IgG) (Athens
Research & Technology; 1:500 dilution), anti-enteropeptidase IgG
(mouse monoclonal) (R&D Systems, Minneapolis, MN; 1:200
dilution) and rabbit anti-ECS (rabbit IgG) (ECS, DDDDK-I) (Bethyl
Laboratories, Montgomery, TX; 1:500) were used for immunostain-
ing. Alexa Fluor 488 or 555 (Molecular Probes, Eugene, OR)
was used for the fluorescence detection. Nuclei were visualized with
40,6-diamino-2-phenylindole. The TUNEL reaction was performed
using a fluorescein in situ cell death detection kit (Roche
Diagnostics) according to the manufacturer’s instructions.
Western blot analysis
Keratinocyte extracts were separated with a 5–20% gradient gel by SDS-
PAGE. After electrophoresis, proteins were transferred onto a poly-
vinylidene difluoride membrane (Immobilon-P; Millipore,
Bedford, MA). Human adult normal tissue proteins blot I was purchased
from Alpha Diagnostic International (San Antonio, TX), in which tissue
extracts from brain, colon, heart, kidney, liver, lung, pancreas and
spleen were blotted on to a nitrocellulose membrane. Membranes were
incubated with anti-human cationic trypsin antibody. Peroxidase-
labeled anti-rabbit IgG (Sigma, St Louis, MO) was used as a secondary
antibody, and immunoreactive proteins were visualized by chemilumi-
nescence using enhanced chemiluminescence-plus (GE Healthcare).
Preparation of skin equivalent models
Skin equivalent models were prepared according to the method of
Tsunenaga et al. (1998) and Amano et al. (2001). Briefly human
keratinocytes were seeded on the surface of type I collagen gel
contracted by human skin fibroblasts. After 2 days of culture,
cornification was induced by lifting the gel to an air–liquid interface
and the culture was continued up to 7 days until the well-differentiated
cornified layer was formed. In another series of experiments, skin
equivalent was fully immersed in the medium and continued to culture
up to 7 days without air exposure. The medium used was a 1:1 mixture
of keratinocyte grown medium and Dulbecco’s modified Eagle’s
medium supplemented with 5% fetal bovine serum, 1.8mM CaCl2 and
250mM 2-O-a-D-glucopyranosyl-L-ascorbic acid.
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